Research in Social and Administrative Pharmacy
Volume 7, Issue 2 , Pages 180-191 , June 2011

Perception and knowledge of patients with type 2 diabetes in Malaysia about their disease and medication: A qualitative study

  • Harith Khalid Al-Qazaz, M.Sc. (Clinical Pharmacy)

      Affiliations

    • Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia
    • Corresponding Author InformationCorresponding author. Tel.: +6 017 4831506.
    • ,
  • Mohamed Azmi Hassali, Ph.D.

      Affiliations

    • Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia
    • ,
  • Asrul Akmal Shafie, Ph.D.

      Affiliations

    • Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia
    • ,
  • Syed Azhar Syed Sulaiman, Pharm.D.

      Affiliations

    • Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia
    • ,
  • Shameni Sundram, M.B.B.S.

      Affiliations

    • Hospital Balik Pulau, Balik Pulau, Penang 11000, Malaysia

References 

  1. World Health Organization . Diabetes. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/Accessed 31.05.09
  2. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for health care professionals from the American Heart Association. Circulation. 1999;100:1134–1146
  3. NHM . The Third National and Morbidity Survey. Available at: http://www.nih.gov.my/NHMS/abstracts_17.html2006;Accessed 23.07.09
  4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes. N Engl J Med. 1993;90:450–459
  5. The UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes. Lancet. 1998;352:837–853
  6. Group DCaCTR. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  7. Vermeire E, Van Royen P, Coenen S, Wens J, Denekens J. The adherence of type 2 diabetes patients to their therapeutic regimens: a qualitative study from the patient's perspective. Pract Diab Int. 2003;20:209–214
  8. Cramer JA. A systematic review of adherence with medication for diabetes. Diabetes Care. 2004;27:1218–1224
  9. Feinstein AR. On white coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150:1377–1378
  10. World Health Organization . Report on Medication Adherence. Geneva, Switzerland: WHO; 2003;
  11. Donovan JL. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care. 1995;11:443–455
  12. Hardeman W, Johnston M, Johnston DW, Bonetti D, Wareham NJ, Kinmonth AL. Application of the theory of planned behaviour in behaviour change interventions: a systematic review. Psychol Health. 2002;17:125–158
  13. Haynes RB, McKibbon KA, Kanai R, et al. Interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383–386
  14. World Health Organization . Adherence to Long Term Therapies: Policy for Action. Geneva, Switzerland: WHO; 2001;
  15. Cleemput I, Kesteloot K. A structural model of health behavior: a pragmatic approach to explain and influence health behaviors at the population level. Prev Med. 2002;30:146–154
  16. Anonymous . Working Party from Compliance to Concordance: Achieving Shared Goals in Medicine-Taking. London, UK: Royal Pharmaceutical society of Great Britain; 1997;
  17. Lewin S, Dick J, Zwarenstein M, Lombard C. Staff education and ambulatory tuberculosis treatment outcomes: a cluster randomized control trial in South Africa. Bull World Health Organ. 2005;83:250–259
  18. Lawton J, Peel E, Parry O, Douglas M. Shifting accountability: a longitudinal qualitative study of diabetes causation accounts. Soc Sci Med. 2008;67:47–56
  19. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331–342
  20. Pope C, Mays N. Qualitative research: reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995;311:42–45
  21. Conrad P. Qualitative research on chronic illness: commentary on method and conceptual development. Soc Sci Med. 1990;30:1257–1263
  22. Berg B. Qualitative Research Methods for the Social Sciences. 5th ed.. Boston, MA: Allyn and Bacon; 2004;15
  23. Smith F. Qualitative Interviews. Research Methods in Pharmacy Practice. London, UK: Pharmaceutical Press; 2002;119–122
  24. Quine S. Interviews. In:  Kerr C,  Taylor R,  Heard G editor. Handbook of Public Health Methods. Sydney, Australia: McGraw-Hills; 1998;p. 522–526
  25. Patton M. Qualitative Research and Evaluation Methods. 3rd ed.. Thousand Oaks, CA: Sage Publication; 2002;243–245
  26. Morse J. The significance of saturation. Qual Health Res. 1995;5:147–149
  27. McCord EC, Brandenburg C. Beliefs and attitudes of persons with diabetes. Fam Med. 1995;27:267–271
  28. Maillet NA, D'Eramo Melkus G, Spollet G. Using focus groups to characterise the health beliefs and practices of black women with noninsulin-dependent diabetes. Diab Educ. 1996;22:39–46
  29. Ooyub S, Ismail F, Daud N. Diabetes program in Malaysia-current and future. NCD Malaysia. 2004;3:6–12
  30. Bloomgarden ZT, Karmally W, Metzger MJ, et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care. 1987;10:263–272
  31. McPherson ML, Smith SW, Powers A, Zuckerman IH. Association between diabetes patients' knowledge about medications and their blood glucose control. Res Soc Adm Pharm. 2008;4:37–45
  32. Sánchez CD, Newby LK, McGuire DK, Hasselblad V, Feinglos MN, Ohman EM. Diabetes-related knowledge, atherosclerotic risk factor control, and outcomes in acute coronary syndromes. Am J Cardiol. 2005;95:1290–1294
  33. Colleran KM, Starr B, Burge MR. Putting diabetes to the test: analyzing glycemic control based on patients' diabetes knowledge. Diabetes Care. 2003;26:2220–2221
  34. Stallwood L. Relationship between caregiver knowledge and socioeconomic factors on glycemic outcomes of young children with diabetes. J Spec Pediatr Nurs. 2006;11:158–165
  35. Yun LS, Hassan Y, Aziz NA, Awaisu A, Ghazali R. A comparison of knowledge of diabetes mellitus between patients with diabetes and healthy adults: a survey from north Malaysia. Patient Educ Counsel. 2007;69:47–54
  36. Berikai P, Meyer PM, Kazlauskaite R, Savoy B, Kozik K, Fogelfeld L. Gain in patients' knowledge of diabetes management targets is associated with better glycemic control. Diabetes Care. 2007;30:1587–1589
  37. Gerber BS, Brodsky IG, Lawless KA, et al. Implementation and evaluation of a low-literacy diabetes education computer multimedia application. Diabetes Care. 2005;28:1574–1580
  38. Overland JE, Hoskins PL, McGill MJ, Yue DK. Low literacy: a problem in diabetes education. Diabet Med. 1993;10:847–850
  39. Rothman R, Malone R, Bryant B, Horlen C, DeWalt D, Pignone M. The relationship between literacy and glycemic control in a diabetes disease-management program. Diabetes Educ. 2004;30:263–273
  40. Chao J, Nau DP, Aikens JE. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus. Clin Ther. 2007;29:177–180
  41. Browne DL, Avery L, Turner BC, et al. What do patients with diabetes know about their tablets?. Diabet Med. 2000;17:528–531
  42. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24
  43. Horne R. Treatment perceptions and self-regulation. In: Cameron L , Leventhal H  editor. The Self-Regulation of Health and Illness Behavior. London, UK: Routledge; 2003;p. 138–153
  44. Bezie Y, Molina M, Hernandez N, Batista R, Niang S, Huet D. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab. 2006;32:611–616
  45. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384–391
  46. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. AmJ Med. 2005;118(Suppl 5A):27S–34S
  47. Williams AF, Manias E, Walker R. Adherence to multiple, prescribed medications in diabetic kidney disease: a qualitative study of consumers' and health professionals' perspectives. Int J Nurs Stud. 2008;45:1742–1756
  48. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64:41–46
  49. Yamakawa M, Makimoto K. Positive experiences of type 2 diabetes in Japanese patients: an exploratory qualitative study. Int J Nurs Stud. 2008;45:1032–1041
  50. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–1412
  51. Vermeire E, Hearnshaw H, Rätsep A, et al. Obstacles to adherence in living with type-2 diabetes: an international qualitative study using meta-ethnography (EUROBSTACLE). Prim Care Diabetes. 2007;1:25–33
  52. Delamater AM. Improving patient adherence. Clin Diabetes. 2006;24:71–77
  53. Aadil N, Houti IE, Moussamih S. Drug taking during Ramadan. BMJ. 2004;329:778–782
  54. Lawton J, Ahmad N, Hallowell N, Hanna L, Douglas M. Perceptions and experiences of taking oral hypoglycemic agents among people of Pakistani and Indian origin: qualitative study. BMJ. 2005;330:1247
  55. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med. 1997;127:1097–1102
  56. Bane C, Hughes CM, Cupples ME, McElnay JC. The journey to concordance for patients with hypertension: a qualitative study in primary care. Pharm World Sci. 2007;29:534–540
  57. Delamater AM, Jacobson AM, Anderson BJ, et al. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care. 2001;24:1286–1292
  58. Glasgow RE, Toobert DJ. Social environment and regimen adherence among type II diabetic patients. Diabetes Care. 1988;11:377–386
  59. Griffith LS, Field BJ, Lustman PJ. Life stress and social support in diabetes: association with glycemic control. Int J Psychiatry Med. 1990;20:365–372

 Conflict of interest: All authors have declared no conflict of interest in connection with this article.

PII: S1551-7411(10)00060-4

doi: 10.1016/j.sapharm.2010.04.005

Research in Social and Administrative Pharmacy
Volume 7, Issue 2 , Pages 180-191 , June 2011

Article Tools